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The citrus red mite, Panonychus citri, is a major pest on citrus all around the world. 
Mitochondrial Electron Transport Inhibitors of complex I (METI-I) acaricides such as 
fenpyroximate have been used extensively to control P. citri populations, which resulted in 
multiple reports of METI-I resistant populations in the field. In this study, biochemical and 
molecular mechanisms of fenpyroximate resistance were investigated in P. citri. Seven 
populations were collected from Northern provinces of Iran. Resistance ratios were determined 
and reached up to 75-fold in comparison to a fenpyroximate susceptible population. Cross-
resistance to two additional METI-I acaricides, pyridaben and tebufenpyrad, was detected. PBO 
synergism experiments, in vivo enzyme assays and gene expression analysis suggest a minor 
involvement of cytochrome P450 monooxygenases in fenpyroximate resistance, which is in 
contrast with many reported cases for the closely related Tetranychus urticae. Next, we 
determined the frequency of a well-known mutation in the target-site of METI-Is, the PSST 
subunit, associated with METI-I resistance. Indeed, the H92R substitution was detected in a 
highly fenpyroximate resistant P. citri population. Additionally, a new amino acid substitution at 
a conserved site in the PSST subunit was detected, A94V, with higher allele frequencies in a 
moderately resistant population. Marker-assisted back-crossing in a susceptible background 
confirmed the potential involvement of the newly discovered A94V mutation in fenpyroximate 
resistance. However, introduction of the A94V mutation in the PSST homologue of D. 
melanogaster using CRISPR-Cas9 did not result in fenpyroximate resistant flies. In addition, 
differences in binding curves between METI-Is and complex I measured directly, in isolated 
transgenic and wildtype mitochondria preparations, could not be found.  
 

















Mitochondrial Electron Transport Inhibitors (METIs) inhibit electron transport in the 
mitochondrial respiratory chain and are commonly and successfully used against phytophagous 
mites like Tetranychus urticae Koch, Panonychus ulmi and Panonychus citri (McGregor) (Acari: 
Tetranychidae) (Hamaguchi et al., 1990; Konno et al., 1990; Van Leeuwen et al., 2015). METIs 
have been classified into groups depending on which of the four complexes (I-IV) of the electron 
transport chain they inhibit. METI-Is act on complex I (group 21, Insecticide Resistance Action 
Committee (IRAC) classification, Version 9.3, June 2019) (Hollingworth et al., 1994; 
Hollingworth and Ahammadsahib, 1995), the proton translocating NADH: ubiquinone 
oxidoreductase, the largest and most complex multi-subunit structure of the respiratory chain 
(Wirth et al., 2016). Complex I is responsible for catalyzing the electron transfer from NADH to 
coenzyme Q10 (ubiquinone). According to previous studies, ubiquinone and complex I inhibitors 
have at least partially overlapping binding sites (Degli Esposti, 1998), consisting of the PSST 
and the 49 kDa subunits (Lümmen, 1998; Schuler et al., 1999; Shiraishi et al., 2012). The PSST 
subunit is the most likely carrier of the iron-sulfur cluster N2 which couples the electron transfer 
to ubiquinone reduction (Duarte et al., 2002; Friedrich, 1998; Magnitsky et al., 2002). 
The METI-I group includes the pesticide rotenone and the acaricides fenpyroximate, pyridaben, 
fenazaquin, pyrimidifen, tolfenpyrad and tebufenpyrad (Hollingworth et al., 1994; Hollingworth 
and Ahammadsahib, 1995). Because of their effectiveness against various mite species, METI-I 
acaricides were rapidly used globally (Devine et al., 2001). Unfortunately, the extensive use of 
this acaricide group resulted in wide-spread resistance (Van Leeuwen et al., 2015). In T. urticae, 
resistance to METI-I acaricides was initially associated with increased P450 activity based on 
synergism and enzyme activity tests (Devine et al., 2001; Herron and Rophail, 1998; Jum et al., 
1995; Ozawa, 1994; Van Pottelberge et al., 2009), and P450 metabolic detoxification was 
suggested to be involved in cross-resistance between different compounds from the METI-I 
group (Kim et al., 2004; Stumpf and Nauen, 2001; Van Pottelberge et al., 2009). Subsequently, a 
genome-wide microarray revealed constitutively overexpressed P450s in T. urticae METI-I 
resistant strains. One of these P450s, CYP392A11, was functionally expressed and able to 
convert fenpyroximate to a non-toxic metabolite (Riga et al., 2015). However, CYP392A11 did 













METI-I metabolism may be compound specific. More recently, Bajda et al. (2017) reported the 
first METI-I target-site related mutation in the T. urticae PSST homologue of complex I (H92R 
substitution, Yarrowia lipolytica numbering). A back-crossing experiment validated the role of 
this target-site mutation in METI-I resistance, although it only explained a part of the total 
resistance phenotype (Bajda et al., 2017). The involvement of the latter mutation in resistance 
was further confirmed for fenpyroximate, pyridaben and tebufenpyrad in a QTL mapping 
approach using bulked segregant analysis (Snoeck et al., 2019).  
The citrus red mite, P. citri, is one of the major cosmopolitan citrus pests (Gotoh et al., 2003; 
Pan et al., 2006; Vassiliou and Papadoulis, 2009), and is also a major pest in Iran (Jafari et al., 
2016). Citrus red mites feed on the sap of leaves, fruits and green shoots of different citrus 
varieties, although the most severe damage is caused to the fruits (Jones and Parrella, 1984). The 
frequent use of pesticides, together with the high reproductive potential and short life cycle of P. 
citri facilitate resistance development in this species (Asano and Kamei, 1977; Ran et al., 2009; 
Yamamoto et al., 1995). METI-I compounds are an important tool in the management of citrus 
mites, and therefore the aim of this study was to investigate resistance levels to fenpyroximate in 
P. citri. Several populations were collected from citrus orchards in northern Iran and the role of 
detoxification as a resistance mechanism was analyzed by synergism experiments and 
biochemical assays. Genome-wide transcriptome profiling was used to identify genes involved in 
METI-I resistance in a subset of the populations. Finally, the role of a newly identified target-site 
(PSST) mutation in METI-I resistance was assessed by marker assisted back-crossing and 
CRISPR-Cas9 genome editing in Drosophila. 
 
2. Materials and methods 
2.1 Mite populations, and chemicals 
In the spring and summer of 2016, P. citri populations were collected from citrus orchards of 
three Northern provinces of Iran, Guilan (Rasht, Rahimabad, Talesh, and Lahijan), Mazandaran 
(Ramsar and Sari) and Golestan (Gorgan) (Figure S1). Noteworthy, only fenpyroximate and 
pyridaben are registered for control of P. citri and Phyllocoptruta oleivorai (Acari: Acariformes: 













citrus trees and collected mites were reared in the laboratory on sour orange leaf discs (Citrus 
aurantium L.) at 25±2 ºC, 60±10% relative humidity (RH) with a 16:8 h (L:D) photoperiod. 
Commercial formulations of fenpyroximate 5% SC (Ortus®), pyridaben 20% SC (Sanmite®), 
tebufenpyrad 20% WP (Pyranica®), and cyenopyrafen 30% SC (Starmite®) were used in toxicity 
bioassays. All chemicals materials were of analytical grade and purchased from Merck 
(Darmstadt, Germany) and Sigma-Aldrich (Diegem, Belgium). 
2.2 Adult bioassays, synergism assays, and cross-resistance screening  
The resistance status of P. citri adult females was determined by the method of Tsagkarakou et 
al. (2009). Briefly, 10-20 female mites were put on the upper side of citrus leaf discs (9 cm2) on 
wet cotton, which had been treated with different concentrations of fenpyroximate at 1 bar 
pressure in a Potter spray tower with 1.5 ml spray fluid (1.5 ± 0.05 mg spray fluid deposit/cm2). 
The concentrations were selected based on preliminary bioassays. A control (distilled water) was 
also prepared. The plates were put in an incubator in controlled conditions at 25 ± 1°C, 60 % RH 
and 16:8 h (L:D) photoperiod. Each bioassay was replicated four times. Mortality was assessed 
24 h after treatment. Mites that could walk normally after being touched with a camel’s hair 
brush were scored as being alive. Resistance to other METI-I acaricides (pyridaben and 
tebufenpyrad) was assessed similarly, while cyenopyrafen toxicity was only tested at a 
concentration of 0.1 and 1 mg a.i. L-1. In order to evaluate synergistic effects, 4 h prior to 
fenpyroximate application, female mites were exposed to nontoxic concentrations of each 
synergist, 500, 300, and 300 mg L-1 of triphenyl phosphate (TPP), piperonyl butoxide (PBO), 
and diethyl maleate (DEM), respectively. Before use, PBO, DEM, and TPP were dissolved in 
acetone and diluted in distilled water. Mites sprayed with synergist only were used as the control. 
LC50 values, slopes, resistance ratios (RR), synergistic ratios (SR) and 95% confidence intervals 
were determined by probit analysis (POLO-Plus, LeOra Software, Berkeley, USA) (Robertson et 
al., 2017). The differences between LC50 values were supposed to be statistically significant 
when the 95% confidence intervals of the ratios did not include the value of 1. 
2.3 Enzyme activity 
Mass homogenates of freshly sampled mites were prepared by crushing 100 adult female mites 
in sodium phosphate buffer (0.1 M, pH 7.6; 350 µl) with a motorized Teflon pestle in glass 













was diluted to 200 µg protein ml−1 and used as an enzyme source. Protein concentration was 
measured by performing the Bradford assay (Bradford, 1976), using the commercially available 
coomassie protein assay kit (Perbio Science) and bovine serum albumin as a standard. The 
activity of esterases (Van Asperen, 1962), GSTs (Habig et al., 1974) and cytochrome P450 
monooxygenases (P450s) (Van Leeuwen et al., 2005) was determined against the model 
substrates α- and β-naphthyl acetate (NA), 1-choloro-2,4-dinitrobenzene (CDNB) and 7-ethoxy-
4-trifluoro methylcoumarin (7-EFC), respectively. Three to four replicates were conducted for all 
previously mentioned enzyme assays. SAS software was used to perform all statistical analyses 
(p ≤ 0.05), means were compared with Tukey’s test statistic (Rodenhouse et al., 2004). 
2.4 RNA-seq 
RNA-extraction of four P. citri populations (Rasht, Lahijan, Ramsar and Sari) was performed in 
Ghent, Belgium. Before RNA extraction, mites were grown on leaves of lemon (Citrus limon 
(L.) Osbeck) in controlled condition, 25 ± 1°C, 60 % RH and 16:8 h (L:D) photoperiod, for at 
least three generations (48 ± 4 days) and a toxicity test with fenpyroximate was performed to 
confirm the resistance status of each population. Total RNA was extracted from 100-130 adult 
female mites of each P. citri population using the RNEasy Plus mini kit (Qiagen, Belgium) with 
four-fold biological replication for each population. The quality and quantity of the total RNA 
was analyzed by a DeNovix DS-11 spectrophotometer (DeNovix, USA) and by running an 
aliquot on a 1% agarose gel. From the RNA samples, Illumina libraries were constructed with 
the TruSeq Stranded mRNA Library Preparation Kit with polyA selection (Illumina, USA). 
Resulting libraries were sequenced on an Illumina HiSeq 2500 and strand-specific paired reads 
(2 x 125bp) were generated (library construction and sequencing was performed at the Genomics 
Core Facility of the University of Utah, Utah, USA). Prior to read-mapping, the quality of the 
reads was verified using FASTQC version 0.11.5 (Andrews, 2010). One replicate (replicate 2) of 
the Rasht population failed to pass the quality control (failure for both “per sequence GC 
content” and “overrepresented sequences”) and was excluded from further analyses. 
2.5 De novo transcriptome assembly and transcript annotation 
For each P. citri population a de novo transcriptome assembly was created using CLC Genomics 
Workbench 11 using a random selection of 10 million reads per replicate per population (for the 













above) and 13.33 million random reads were used per replicate per population for the Rasht de 
novo assembly). Next, resulting assemblies were merged and long open reading frames (ORFs) 
of each transcript were extracted using Transdecoder v. 5.2.0 (Haas et al., 2013) with a minimum 
ORF length of 100 amino acids. Next, extracted ORFs were filtered using CD-HIT-EST (Li and 
Godzik, 2006) with an identity threshold of 98% (-c 0.98) and a word size of 10 (-n 10). Those 
transcripts to which the filtered ORFs belonged (from here on named “merged assembly”) were 
used for further analysis (see below). The overall mapping success rate against the merged 
assembly was used as a measure for assembly quality. The P. citri transcript encoding the PSST 
subunit of complex I (see Introduction) was identified based on a tBLASTn search using the T. 
urticae PSST subunit (tetur07g05240) as query. Furthermore, all transcripts of the final assembly 
were loaded into OmicsBox 1.1.78 and used as query in a BLASTx 2.9.0+ search, using an E-
value threshold of E-3 and the “fast” setting (Shiryev et al., 2007), against the NCBI non-
redundant (nr) protein database (version of 20th February 2019). Blast2GO was subsequently 
used to map and annotate gene ontology (GO) terms to transcripts based on the sequence hits 
retrieved by the BLASTx search (Götz et al., 2008). Finally, the InterProScan pipeline (Finn et 
al., 2016) was run and InterPro identified GO terms were merged to the Blast2GO annotated GO 
terms.  
2.6 Expression quantification and principal component analysis (PCA) 
Before read alignment, those transcripts that had a BLASTx hit with either Citrus sp. or viruses 
were excluded from the final assembly. Paired-end sequences were pseudoaligned with kallisto 
(100 bootstraps) to create abundance-estimates (Bray et al., 2016). Differential expression 
analyses were performed with sleuth 0.29.0 running on R 3.4.4 according to sleuth default 
settings, and by using the following R-packages; biomaRt 2.34.2, edgeR 3.20.9, limma 3.43.9, 
dplyr 0.7.6 and bindrcpp 0.2.2. The Wald test in sleuth was used to analyze the kallisto bootstrap 
estimates (Pimentel et al., 2017) while the transformation function log2(x + 0.5) (Sahraeian et al., 
2017) option in the sleuth_prep command was used to calculate the effect size (β value) as log2-
based fold changes. Transcripts with a |log2FC| ≥ 1 and q-value (Benjamini-Hochberg multiple 
testing corrected p-value) ≤ 0.05 between the susceptible (Rasht) and one of the resistant 
(Lahijan, Ramsar and Sari) P. citri populations were considered as differentially expressed. For 













was performed using the Bioconductor package GOSeq (version 1.24.0) (Young et al., 2010). 
The resulting p-values from GOSeq were corrected using the Benjamini-Hochberg method 
(Benjamini and Hochberg, 1995) and only those GO categories with an adjusted p-value of less 
than 0.05 were considered significantly enriched. Finally, a PCA was created using the R-
packages sleuth, dplyr 0.7.6 and ggplot2 3.0.0. 
2.7 cDNA synthesis and RT-qPCR 
A set of DETs between two P. citri populations (Rasht and Sari) was evaluated by RT-qPCR. 
Gene specific primers were designed using Primer3 v.0.4.0.0 (Rozen and Skaletsky, 2000). The 
RT-qPCR primers used, including the primers for the genes of interest, as well as those for the 
two reference genes (GAPDH and ELF1a, Niu et al., 2012), can be found in Table S4. Total 
RNA was extracted as described above, and 2 μg of total RNA was used as template for 
synthesizing cDNA with the Maxima First Strand cDNA synthesis Kit for RT-qPCR (Fermentas 
Life Sciences, Aalst, Belgium). Three biological and two technical replicates were used and non-
template controls were added to exclude sample contamination. The RT-qPCR analysis was 
performed on a Mx3005P qPCR thermal cycler (Stratagene, Agilent Technologies, Diegem, 
Belgium) with Maxima SYBR Green qPCR Master Mix (2x) and ROX solution (Fermentas Life 
Sciences) according to the manufacturer’s instructions. The run conditions of the RT-qPCR were 
as follows: 95 °C for 10 min followed by 35 cycles of 95 °C for 15 s, 55 °C for 30 s and 72 °C 
for 30 s. Finally, a melting curve was generated (from 65 °C to 95 °C, 1 °C per 2 s), to confirm 
the presence of a single amplicon. The standard curve and amplification efficiencies of each 
primer pair were detected using fourfold dilution series of pooled cDNA. The resulting 
amplification efficiencies were incorporated in the calculations of the expression values. Relative 
expression levels and significant gene expression differences (one-sided unpaired t-test) were 
calculated using qbase + version 3.0 (Hellemans et al., 2007). 
2.8 Single mite DNA preparation and amplification of PSST fragment 
To perform DNA extraction on single P. citri males, individual males were homogenized in 20 
µl STE buffer (100 mM NaCl, 10 mM Tris-HCl, and 1 mM EDTA) with 2 µl (10 mg/ml) 
proteinase K (Sigma-Aldrich). Homogenate was incubated at 60 °C for 30 min followed by 
proteinase K inactivation for 5 min at 95 °C. After cooling, homogenate was directly used in a 













Rasht_contig_1338, encoding a P. citri PSST fragment (see Table S4 for primer sequences). 
Resulting DNA was Sanger sequenced by LGC Genomics (Germany), and analysed using 
BioEdit 7.0.1 software (Hall, 1999). For each P. citri population (Rasht, Lahijan, Ramsar and 
Sari), the PSST fragment of 20 single males was amplified and sequenced. 
2.9 Introgression of the A94V PSST mutation into a susceptible background 
Introgression by marker assisted selection was performed as previously described by Bajda et al. 
(2017). Briefly, a virgin female of the Rasht population (susceptible to fenpyroximate, genotype 
A94/A94 for PSST) was crossed with a haploid male of the Lahijan population (fenpyroximate 
resistant, genotype V94/V94 for PSST), in two biological replicates. The heterozygous virgin 
females (genotype A94/V94) were crossed with Rasht males (A94 genotype). After they had laid 
enough eggs, presence of the target-site mutation was determined in the heterozygous F1 females 
with PCR-RFLP using a TseI restriction site (New England BioLabs® Inc.) (Table S4 and Table 
S5). The back-cross was repeated for six generations and in the last generation, heterozygous 
females were crossed with their sons which had either the genotype A94 or V94; resulting in 
homozygote lines with genotypes A94/A94 (S-line) and V94/V94 (R-lines). Fenpyroximate 
toxicity to S and R-lines was assessed as above. 
2.10 CRISPR-Cas9 genome editing in Drosophila 
2.10.1 Strategy for genome editing 
An ad hoc CRISPR-Cas9 strategy was implemented in order to generate Drosophila strains 
bearing mutation A94V (Yarrowia lipolytica numbering, corresponding to A105V in 
Drosophila PSST and corresponding to A112V in T. urticae PSST) at the PSST (ND20) gene, 
similar to the one used in Bajda et al. (2017). Two CRISPR targets, sgRNA1 and sgRNA2 
were used (Figure S2) as previously described (Bajda et al., 2017) and the same sgRNA 
expressing plasmids were employed. A double stranded donor plasmid (File S1, insert size 
2183bp), was synthesized de novo (GenScript, USA) to facilitate homologous recombination, 
containing two homology arms of circa 950 bp length spanning the 286 bp target region that 
contains the A105V (GCT->GTT; A94V in Y. lipolytica) mutation as well as certain 
additional synonymous mutations (Figure S2) serving either as molecular markers (to 













of the donor. These include a mutation resulting in the abolishment of a Tsp45I restriction 
site, as well as the introduction of a SgrBI site in genome modified alleles (Figure S2). 
2.10.2 Molecular screening and establishment of genome modified lines.  
nos.Cas9 pre-blastoderm embryos were injected with a mix containing 75 ng/μl of each 
sgRNA plasmid vector and 100ng/μl of donor template. Hatched larvae were transferred into 
standard fly artificial diet and after 9-13 days surviving G0 adults were collected and 
individually backcrossed with nos.Cas9 flies. In order to screen for CRISPR events, G1 
generation progeny from each cross were initially screened en masse followed by individual 
crosses as previously described (Bajda et al., 2017; Douris et al., 2016). DNA pools from c. 
30 individuals or individual flies were used for amplification with specific primers 
CG9172_dia_F/R (Table S4) that were designed accounting for the synonymous mutations 
introduced in the relevant target sequences in order to generate a 294 bp diagnostic fragment 
that is specific to genome modified alleles, but not wild-type ones (Figure S3A). PCR was 
performed with Kapa Taq polymerase as previously described (Bajda et al., 2017) using ~60 
ng of digested template DNA mix. An alternative strategy was also used, which consisted of 
PCR amplification with a “generic” primer pair CG9172_ver F/R (Table S4) which was 
designed to amplify a 559 bp fragment that may be derived by either wild type or genome 
modified alleles. Following PCR amplification, the product was digested with the diagnostic 
enzyme SgrBI introduced in the donor plasmid sequence, producing two diagnostic fragments 
of 328 and 231 bp (Figure S3B). Crosses that proved positive for genome modified alleles 
were further explored to identify individual flies bearing mutant alleles and to establish 
homozygous lines (see Figure S4 for the whole crossing scheme). DNA was extracted from 
several homozygous female and hemizygous male adults, amplified by using primers 
CG9172F/R or CG9172_ver F/R (Table S4), and the relevant amplification fragments were 
sequence verified (Cemia, Larissa, Greece) for the presence of the desired mutations (Figure 
S3C). 
2.10.3 Toxicity bioassays with Drosophila nos.Cas9 or PSST A94V mutant 
Tebufenpyrad, pyridaben and fenpyroximate of technical grade were purchased from Sigma 
Aldrich (Darmstadt, Germany) and used in contact assays and/or topical applications with 













2019). More specifically, 10 adult female flies (1 to 3-days old) were used in each toxicity 
assay. Flies were collected in plastic vials and transferred in scintillation vials coated with 
insecticide. Serial dilutions of 6 to 7 concentrations of technical grade METIs in acetone were 
used for dose response bioassays, while vials coated only with acetone served as control. The 
vials were plugged with cotton that was kept moist with 5% sucrose solution. Each METI 
bioassay was tested in 3 replicates. Mortality was scored after 24 h.  
Topical application of fenpyroximate was performed on 1 to 3-days old female flies. 
Fenpyroximate was dissolved in acetone and serial dilutions were used to generate the 
appropriate concentrations. Each dose was applied as a volume of 1 μl per fly using a 10 μl 
Hamilton syringe. Flies were immobilized by keeping them on an ice-cold slide. For each 
concentration 40-45 flies were tested. Following insecticide application, the flies were 
transferred in glass scintillation vials covered with cotton moisturized with 5% sucrose 
solution. The vials were maintained in a 25°C incubator while mortality was scored after 24 h. 
2.11.4 NADH:ubiquinone oxidoreductase activity measurements and ligand pIC50 
determination 
Mitochondria of either the nos.Cas9 or A94V mutant fly line were isolated from the thoracic 
flight muscles of 5-7 day old flies by a modification of the procedure described by Wood and 
Nordin (1980). Briefly, thoraces were excised from approximately 150 adult female flies and 
homogenized with a Teflon pestle in 3 ml chilled buffer I (154 mM KCl, 1 mM EDTA, pH 
adjusted to 7.2 with KOH, Halt Protease Inhibitor Cocktail (100X) - Thermo Fisher Scientific). 
Cooled homogenate was centrifuged twice at 500g followed by syringe filtration through 8 
layers of a sterile gauze. Flow-through was centrifuged once at 5000g for 10 min. The resulting 
pellet was washed once in 800 µl of buffer I. Mitochondria were pelleted at 5000 g for 10 min 
and resuspended in 100 µl of buffer II (200 ml Mannitol, 50 mM Sucrose, 1 mM EDTA, in 10 
mM HEPES, adjusted with NaOH to pH 7.2). Mitochondria isolation was performed in triplicate 
per line. One out of three A94V mutant fly lines was selected to perform the mitochondrial 
extractions. 
 
For measurement of NADH:ubiquinone oxidoreductase activity, a combined assay for 













reduced ß-NADH (TCN Biochemicals) as substrate and monitoring the reduction of cytochrome 
c by following the increase in optical density at 550 nm was used as published previously (Hatefi 
and Stiggall, 1978). In brief, cytochrome c from equine heart (Sigma, C2506) was mixed with 
NADH and a sodium cyanide solution for final concentrations of 0.93 mg/ml, 40 µM and 61 
µg/ml respectively. Sodium cyanide prevented reduced cytochrome c from being oxidized by 
cytochrome c:02-oxidoreductase also present in mitochondria. 25 µl of this cytochrome c 
solution was added to 25 µl mitochondrial protein/inhibitor solution. This protein/inhibitor 
solution contained material for final concentrations of 1.25 mg/ml CHAPS (Sigma C3023) and 
125 mM KCl (Merck 1.04936.1000) dissolved in potassium buffer pH 7.2 c(PO4)=50 mmol/L as 
well as the investigated inhibitors as applicable. 
All assays including enzyme activity measurements and IC50 determinations were performed in a 
final volume of 50 μl containing inhibitor stocks dissolved in DMSO with a final DMSO 
concentration of 0.1%. The concentration range of inhibitors was 0.64 pM – 10 µM. Each 
concentration was tested in two technical replicates and 2-3 biological replicates. The enzyme 
activity was calculated based on two control reactions (no inhibitors and 100 nM fenazaquin in 
DMSO). As enzyme activity varies by each isolation of mitochondria, the amount of 
mitochondria used in each reaction was adjusted to be in line with the requirements of the 
activity assay. All enzyme activity measurements and IC50 determinations were carried out in 
384-well plates (384 flat bottom transparent, Greiner) using a TECAN Infinity multimode 
microplate reader (Tecan Group Limited., Switzerland). pIC50 values (= negative logarithm of 
IC50) were calculated using the R-package drc (Ritz et al., 2015). A four-parameter logistic curve 
(LL.4) was fitted to the dose-response (% inhibition relative to inhibition by 100 nM fenazaquin) 
data using the drm function within the drc package and statistical difference between pIC50s of 
METI-Is was determined by means of a t-test using the compParm function within drc. 
 
3. Results 
3.1 METI resistance levels and detoxification enzyme activities in P. citri populations from 
Iran 
Fenpyroximate toxicity was assessed in seven P. citri populations (Table 1). Fenpyroximate was 













as the susceptible population. Relative to the Rasht population, the highest resistance ratios 
(RRs) were found for the Ramsar and Sari populations (>76.1 fold) while moderate RRs were 
determined for the Rahimabad, Gorgan, Talesh and Lahijan populations (7.0, 7.3, 19.8 and 19.9 
fold, respectively). TPP significantly synergized fenpyroximate toxicity for the Gorgan, Talesh, 
Rahimabad and Lahijan population, while DEM only significantly synergized fenpyroximate 
toxicity for the Talesh and Rahimabad population. However, low synergism ratios (SRs) were 
observed for both TPP (1.3-3.0 fold) and DEM (1.0-1.7 fold). PBO, on the other hand, 
significantly reduced the toxicity of fenpyroximate in all tested populations and PBO SRs were 
higher (3.0-6.3 fold) than those determined for TPP and DEM. Across all P. citri populations, the 
Rahimabad population had the highest SR for both DEM, TPP and PBO. PBO SRs could not be 
determined for the Ramsar and Sari population since LC50s were higher than 500 mg/L, the 
upper limit of our toxicity assay. The Sari population also showed high levels of resistance to 
pyridaben and tebufenpyrad, relative to the susceptible Rasht population (RR: 31.725 and 
259.250 fold, respectively) (Table 2). Lahijan and Ramsar also showed moderate resistance for 
tebufenpyrad (RR: 18.967 and 23.490). For cyenopyrafen, LC50s were not determined but 100% 
mortality was observed at a concentration of 0.1 and 1 mg a.i. L-1 for the Rasht, Lahijan, Ramsar 
and Sari population.  
The in vitro activities of CCEs, GSTs and P450s were determined on whole mite homogenates of 
P. citri populations and are presented in Table 3. Esterase (α-NA) and GST activities were 
significantly higher in the Gorgan and Talesh population compared to the Rasht population, with 
a 6.155- fold and 2.196- fold increase in esterase (α-NA) and GST activity, respectively, in the 
Gorgan population. Of the four METI-I resistant populations examined, only the Lahijan 
population had a P450 activity that was significantly higher (1.6-fold) than the susceptible Rasht 
population.  
3.2 de novo assembly, RNA sequencing, PCA and differential transcript expression analysis  
Illumina sequencing generated approximately 53,074-72,328 million strand-specific, paired-end 
reads per population. Reads of each population are available in the Gene-Expression Omnibus 
(GEO) repository with accession number GSE142139. The final de novo assembly consisted of 
17,784 transcripts (File S2) and was generated by merging the de novo transcriptome assembly 













merged transcripts was 2,378 bp and the average pseudoalignment mapping rate of reads against 
the 17,784 transcripts was 90% ± 1.1 STD, consistent with a high-quality transcriptome 
assembly (Table S1). A Blast2GO analysis revealed that 15,508 of the 17,784 transcripts had a 
BLASTx hit (Table S2) and 102 transcripts were either viral or from Citrus sp. (Table S3). These 
102 transcripts were removed from further analyses. Next, reads were pseudoaligned against the 
17,682 non-viral/non-citrus transcripts (see Supplementary File of GEO accession GSE142139) 
using kallisto. A principal component analysis (PCA) across all RNAseq samples revealed that 
45.86% of the total variation could be explained by PC1 while 30.15% could be explained by 
PC2 (Figure 1). RNAseq replicates clustered by population, confirming sample quality. We used 
sleuth to perform a differential transcript expression analysis (|log2FC| ≥ 1, q-value ≤ 0.05). 
Transcript expression levels were pairwise compared between each resistant mite population 
(Lahijan, Ramsar and Sari) and the susceptible (Rasht) population.  
The Sari population differed the most from the susceptible Rasht population and had 904 DETs, 
whereas the Ramsar and Lahijan population only had 520 and 414 DETs, respectively. For a 
subset of transcripts, differential expression was validated independently by RT-qPCR (Figure 
S5). As shown in Figure 1C, the majority of DETs were not shared between the three 
comparisons, but 331 DETs (36.6% and 63.6% of the total number of DETs of Sari and Ramsar, 
respectively) were shared between the Ramsar and Sari populations (Table S6 and Table S7). In 
contrast, the majority of differentially expressed transcripts were population-specific for Lahijan. 
These findings align with the PCA results, with Sari and Ramsar clustering on PC2 away from 
Lahijan (Figure 1B). A GO enrichment analysis revealed that among the DETs between the 
Lahijan and Rasht populations five GO terms were significantly enriched, including “positive 
regulation of translational elongation/termination” (GO0045901, GO0045905) and “translational 
frameshifting” (G0006452) (Table S8), while among the DETs of the other comparisons no 
significantly enriched GO-terms were found. Only a few P450 transcripts were differentially 
expressed in the resistant P. citri populations, with fold changes being modest overall. Ramsar 
(three overexpressed contigs, log2FC 1.1-1.6) and Sari (six overexpressed contigs, log2FC 1.2-
3.9) shared one overexpressed P450 contig (Lahi_contig_11061) while Lahijan had only one 
uniquely overexpressed P450 (Rasht_contig_4055, log2FC of 1.1) (Table S7). 
Ramsar_contig_7025 encodes a NFU1 iron-cluster scaffold protein and was one of the most 













Ramsar_contig_3746 and Rasht_contig_6350, encoding the NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 4 (orthologous to human NDUFS4) and the iron-sulfur cluster assembly 2 
protein (orthologous to human ISCA2), respectively, where 5 and 2-fold overexpressed in these 
strains (Table S7). Finally, Sari_contig_3709 was about 6-fold overexpressed in both Sari and 
Ramsar and encodes the beta subunit of the mitochondrial NAD+ dependent isocitrate 
dehydrogenase (orthologous to human IDH3B), an enzyme of the tricarboxylic acid cycle, while 
a metal regulatory transcription factor 1 (MTF-1) encoding transcript (Rasht_contig_582) was 
underexpressed in both Ramsar and Sari (Table S6 and Table S7). 
3.3 Presence of PSST mutations in P. citri populations 
A PSST fragment from 20 single males of the Rasht, Lahijan, Ramsar and Sari population was 
PCR amplified and analyzed for the presence of the previously reported H92R mutation (Bajda 
et al., 2017). The mutation was observed in some populations. Males of the Sari population had 
the highest frequency of the H92R mutation (35%), while the frequency was 5%, 10% and 10% 
for males of Rasht, Lahijan and Ramsar populations, respectively. In addition, we identified a 
previously unreported PSST mutation, A94V. The A94V mutation was found in one Rasht male, 
while 55% of the Lahijan males harbored the A94V mutation (Figure 2). 
3.5 Marker-assisted back-crossing of PSST A94V into a susceptible P. citri background. 
The marker-assisted back-crossing experiments successfully generated two independent lines 
with the A94V substitution fixed in the susceptible background of the Rasht population. The 
fenpyroximate and pyridaben toxicity profile for the parental and back-crossed P. citri 
populations are reported in Table 4. The two introgressed replicate lines S1 and S2, without the 
A94V mutation, had fenpyroximate RRs of 0.71 and 0.82 compared to the susceptible Rasht 
population. In contrast, the two introgressed replicate lines R1 and R2, with the A94V mutation, 
had fenpyroximate RRs of 9.17 and 10.68, respectively, compared to the susceptible Rasht 
population. The RRs for pyridaben (1.7 and 1.4 for R1 and R2, respectively) were less 
pronounced (Table 4). 
3.6 Introduction of A94V in the PSST homologue of Drosophila by CRISPR-Cas9 followed 













The A94V mutation (Y. lipolytica numbering, A105V Drosophila numbering) was introduced 
in Drosophila via CRISPR/Cas9 coupled with Homologous Directed Repair (HDR) as 
described in Materials and Methods. Following injection of nos.Cas9 embryos, 46 adult (G0) 
flies were backcrossed with nos.Cas9 flies and generated viable progeny (G1). Samples from 
these G1 flies were screened and 4 were found to be positive for HDR (Figure S3). These lines 
were crossed to balancer stocks as shown in Figure S4 and three of them generated 
homozygous lines bearing the A94V sequence at the target gene (Figure S3C). Contact and 
topical bioassays were used to investigate the toxicity of METI-I acaricides to Drosophila 
nos.Cas9 and the three A94V lines. Contact assays revealed that at 10, 100 or 1000 mg/L 
pyridaben fly mortality was significantly lower in the nos.Cas9 line compared to the A94V 
lines. Similarly, at 1000 mg/L tebufenpyrad, fly mortality was lower in the nos.Cas9 line 
compared to the A94V lines, albeit not significantly (p-value= 0.0722). On the other hand, 
5,000 mg/L fenpyroximate was not toxic to Drosophila in contact assays (Figure S6). Topical 
assays with fenpyroximate, on the other hand, showed fly mortality at 1,000, 2,500 and 5,000 
ppm fenpyroximate but no significant differences could be observed between the mean 
mortality of nos.Cas9 and A94V fly lines (Figure 3). 
3.7 NADH:ubiquinone oxidoreductase activity measurements and ligand pIC50 determination 
The inhibition curves of tebufenpyrad, fenpyroximate and pyridaben for complex I of 
mitochondria prepared from nos.Cas9 and A94V Drosophila lines are shown in Figure 4. The 
pIC50 values (95% CI) of tebufenpyad, fenpyroximate and pyridaben were 8.87 (8.78-8.96), 8.15 
(8.05-8.26) and 8.48 (8.35-8.61) for the nos.Cas9 line, respectively, and 8.90 (8.81-8.98), 8.26 
(8.16-8.36) and 8.46 (8.32-8.61) for the A94V line, respectively. The pIC50 values of 
tebufenpyrad, fenpyroximate and pyridaben were similar (nanomolar range) to a previously 
reported pIC50 value of pyridaben for complex I from rat liver mitochondria (Hollingworth et al., 
1994). No significant differences were found between METI-I acaricide pIC50 values of the 















According to the Arthropod Resistance Pesticide Database, 74 resistance cases to 28 different 
acaricides have been reported for P. citri, including the METI-I pesticide pyridaben (Mota-
Sanchez and Wise., 2019).  Resistance to, and cross-resistance between, METI-I group acaricides 
has been reported from the mid-1990s in spider mites (Van Leeuwen et al., 2009). Although 
METI-I resistance is well studied for T. urticae and P. ulmi, knowledge on incidence and 
mechanisms of METI-I resistance is far more limited for P. citri. In this study, we characterized 
fenpyroximate resistance in seven P. citri populations from Iran. The lowest fenpyroximate LC50 
(6.57 mg/L) was found for the Rasht population (Table 1) and was similar to the LC50 typically 
found for susceptible T. urticae strains determined with the same methods (Van Pottelberge et 
al., 2009). Other sampled P. citri populations showed low to high fenpyroximate resistance ratios 
(RRs) compared to the Rasht population. The highest fenpyroximate RR was found for the Sari 
population (RR > 76 fold) and was considerably higher than those reported for Panonychus sp. in 
previous studies (Kumral and Kovanci, 2007; Nauen et al., 2001), but lower than those reported 
for T. urticae (> 500-fold, Nauen et al., 2001; Stumpf and Nauen, 2001; Van Pottelberge et al., 
2009). For four populations we also examined resistance to two other METI-I acaricides, 
tebufenpyrad and pyridaben, and a METI-II acaricide, cyenopyrafen. The P. citri Sari population 
showed high levels of resistance to pyridaben and tebufenpyrad, while the Lahijan and Ramsar 
populations showed moderate resistance only to tebufenpyrad (Table 2). METI-I cross-resistance 
has been reported numerously for tetranychid species (see Kim et al., 2004; Stumpf and Nauen, 
2001; Van Pottelberge et al., 2009), and since tebufenpyrad and pyridaben are not registered or 
rarely used in citrus orchards in Iran (Nourbakhsh, 2018), this strongly suggests that there is 
moderate to high levels of cross-resistance between fenpyroximate and other METI-I acaricides 
in the fenpyroximate resistant P. citri strains of this study. Cross-resistance between pyridaben 
(METI-I) and cyenopyrafen (METI-II), on the other hand, has only been recently reported for T. 
urticae (Khalighi et al., 2016; Sugimoto and Osakabe, 2014), and such cross-resistance was not 
observed for the resistant P. citri populations in this study.  
Low levels of synergism were observed following pre-treatment of fenpyroximate-sprayed mites 
with either TPP or DEM in the P. citri populations of this study. Overall, this is in line with the 
in vitro determined activities of detoxification enzymes that are blocked by these synergists, with 
elevated CCE and GST activities observed only for the Gorgan and Talesh populations, which 













synergized fenpyroximate toxicity in the resistant P. citri populations but, to a similar extent, 
also in the susceptible Rasht population, suggesting that P450s do not play a major role in 
fenpyroximate resistance in these resistant P. citri populations. PBO SRs could not be 
determined for the highly fenpyroximate resistant P. citri populations Sari and Ramsar. 
However, as we only observed elevated P450 enzyme activity in the Lahijan population (Table 
3) and not in the Sari or Ramsar populations, P450s likely do not play a major role in 
fenpyroximate resistance in the latter populations. For T. urticae, the effect of PBO on 
fenpyroximate toxicity has often been found to be high (Ay and Kara, 2011; Kim et al., 2004; 
Van Pottelberge et al., 2009). In addition, Riga et al. (2015) showed that fenpyroximate could be 
metabolized in vitro by a recombinant T. urticae P450 (CYP392A11), and transgenic Drosophila 
flies ectopically expressing CYP392A11 showed threefold resistance to fenpyroximate. 
However, the in vivo role of this P450 in fenpyroximate resistance in T. urticae has still not been 
demonstrated. 
To identify putative players in fenpyroximate resistance on a genome wide scale, we performed a 
differential expression analysis between a selection of fenpyroximate resistant P. citri 
populations (Lahijan, Sari and Ramsar) and a susceptible population (Rasht). In line with the 
results from the PBO synergism experiments and P450 enzyme activity measurements, we found 
few P450 transcripts among the DETs. Among the DETs shared between the two most resistant 
populations (Sari and Ramsar), some may play a role in fenpyroximate resistance (Table S6, 
Table S7). The NFU1 homolog in bacteria (NfuA) is known to be crucial for complex I stability 
(Bandyopadhyay et al., 2008) and for protection against oxidative stress (Burschel et al., 2019; 
Melber et al., 2016; Zimbler et al., 2012) while ISCA2 and NDUFS4 mutants in humans were 
shown to have severely reduced complex I activity (Al-Hassnan et al., 2015; Budde et al., 2000; 
Petruzzella et al., 2001; Sheftel et al., 2012). Their overexpression in Ramsar and Sari might be a 
“compensation mechanism” for fenpyroximate inhibition of complex I and the resulting 
oxidative stress, the latter being the primary mechanism of METI-I toxicity (Sherer et al., 2007). 
Mitochondrial NAD+ dependent isocitrate dehydrogenase is located in close vicinity of complex 
I (Porpaczy et al., 1987) and generates NADH, which is used by complex I to drive electron 
transport (Al-Khallaf, 2017; Larosa and Remacle, 2018). The overexpression of its encoding 
transcript in fenpyroximate resistant P. citri populations seems counterintuitive as it was shown 













Similarly, we also observed underexpression of an MTF-1 encoding transcript. This observation 
contradicts earlier findings that indicated that overexpression of MTF-1 confers resistance 
against oxidative stress (Bahadorani et al., 2010; Saini et al., 2011). 
In the closely related T. urticae, METI-I-resistance is a complex mechanism, including both 
detoxification by P450s and target-site resistance conferred by H92R in the PSST subunit of 
complex I (Bajda et al., 2017; Snoeck et al., 2019). In the PSST transcript of the Sari population 
we identified an identical mutation and subsequently monitored the presence of this mutation in 
20 single males of the Rasht, Lahijan, Sari and Ramsar population. We found that the PSST 
H92R mutation was segregating in all P. citri populations, but that the Sari population, the only 
population that was resistant to all three tested METI-I acaricides (Table 1, Table 2) had the 
highest H92R allele frequency (35%). The association of the PSST H92R mutation with METI-I 
resistance in P. citri, which belongs to the same subfamily as T. urticae (Tetranychinae), 
provides a new example of parallel evolution and further supports the role of this mutation in 
METI-I resistance. Additionally, in the PSST subunit of the Lahijan population we identified a 
new mutation, A94V, located two amino acids away from the H92R mutation. Like H92, A94 
belongs to a PSST fragment that was photoaffinity labeled by a photoreactive derivative of 
fenpyroximate (Shiraishi et al., 2012, Figure 2A - residues of B. taurus PSST in grey font). A 
PROVEAN (PROtein Variation Effect ANalyzer) analysis also predicted that a mutation to 
valine at this position is deleterious (PROVEAN score -3.752, Choi and Chan, 2015). Because of 
its closely adjacent proximity to the H92R mutation and the predicted deleterious effect, we 
investigated the frequency of the A94V mutations in single males of the Rasht, Lahijan, Ramsar 
and Sari populations. The A94V mutation was found in only one male of the Rasht population, 
was absent in the Sari and Ramsar populations, but is present in more than half of the males of 
the moderately resistant Lahijan population (Figure 2B), suggesting a possible association with 
moderate resistance against fenpyroximate. Similar as in Bajda et al. 2017, the role of this 
mutation in METI-I resistance was further investigated by marker-assisted back-crossing 
between a resistant (Lahijan) and a susceptible (Rasht) population. In this way, we aimed to 
uncouple the mutation from other resistance conferring genes by reducing the genetic 
background of the resistant parent to a minimum (Hospital, 2005). Remaining fenpyroximate 
resistance levels were about 10-fold compared to the susceptible Rasht population (Table 4), 













the Lahijan population could not be completely explained by the A94V mutation, this might 
suggest that multiple factors play a role in resistance of the Lahijan population against 
fenpyroximate. 
Back-crossing reduces the proportion of donor genome by 50% each generation, except on the 
chromosome carrying the characteristic, which will have a slower rate of decrease as a result of 
linkage drag (Naveira and Barbadilla, 1992). Therefore, to further test the possibility that A94V 
is involved in resistance, we used CRISPR-Cas9 technology to introduce the mutation in the 
PSST homologue of D. melanogaster. CRISPR-Cas9 modified Drosophila A94V lines were 
successfully created. Of particular note, complex I activity in a PSST S94A mutant of Y. 
lipolytica was also not significantly different from wild-type Y. lipolytica (Yoga et al., 2019). 
These findings are in contrast to the H92R PSST mutation reported by Bajda et al. (2017), where 
CRISPR-Cas9 modified H92R Drosophila flies were not viable.  
The A94V gene-edited flies did not show elevated fenpyroximate, tebufenpyrad or pyridaben 
resistance (Figure 3, Figure S6). Moreover, A94V mutant flies were significantly more 
susceptible to pyridaben compared to nos.Cas9 flies (Figure S6). In addition to toxicity tests, we 
also performed complex I inhibition experiments with mitochondria extracted from nos.Cas9 and 
A94V mutant flies. In line with the toxicity experiments, no significant differences in complex I 
inhibition were observed (Figure 4). This might suggest that resistance in back-crossed resistant 
P. citri lines was potentially caused by hitchhiking of a linked causal locus (an effect of linkage 
drag). However, as a P. citri genome has not yet been published, we could not investigate 
potential genes of importance in close proximity to the PSST gene. Alternatively, it could be that 
the A94V mutation has an effect only in mites and not in insects, but to investigate such 
hypothesis one needs to study isolated mite mitochondria directly, a procedure that proved 
unsuccessful in our hands for P. citri. The alternative, to introduce the mutation by e.g. CRISPR-
Cas9, is currently also not feasible in mites.  
To conclude, the rise of METI-I resistance is an important challenge in the control of 
herbivorous mites such as P. citri. PBO synergism experiments, in vivo enzyme assays and gene 
expression analysis suggest a minor involvement of P450s in fenpyroximate resistance, which is 
in contrast with many reported cases for T. urticae. Genome wide gene expression analysis also 













of genes were identified that might represent novel resistance genes, but need to be functionally 
validated. However, we identified a previously reported target-site resistance mutation, H92R in 
the PSST subunit of complex I, for the first time in P. citri, a striking demonstration of parallel 
molecular evolution between these species. In addition, we also identified a new mutation, 
A94V, in proximity of the H92R mutation and predicted to be deleterious. However, in spite of 
thorough investigations by marker-assisted back-crossing and mutant Drosophila flies, our 
results did not allow to make a clear claim regarding the involvement of A94V in fenpyroximate 
resistance. 
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Figure 1 - Transcriptome analysis of three fenpyroximate resistant P. citri populations.  
(A) Volcano plot depicting differentially expressed transcripts between the fenpyroximate 
resistant strains (Sari, Ramsar and Lahijan) and the fenpyroximate susceptible strain Rasht. 
Differentially expressed transcripts with an absolute log2FC ≥1 are coloured in red. (B) PCA plot 
of gene expression levels of all four P. citri populations. For each population, Rasht, Lahijan, 
Ramsar and Sari, convex hulls were added for easier visual interpretation. (C) Venn diagram 
depicting overlap among differentially expressed transcripts (red: overexpressed, blue: 
underexpressed) in adult P. citri females from the three fenpyroximate resistant populations 
(Sari, Ramsar and Lahijan) compared to adults from the susceptible Rasht population (log2FC 
≥1, q-value ≤0.05). 
 
Figure 2 - Frequency of H92R and A94V mutations in single males of four populations of 
P.citri. A) Alignment of a P. citri PSST fragment with those of other Metazoa, Yarrowia 
lipolytica and T. aquaticus. The H92R and A94V mutation (Y. lipolytica numbering) are 
indicated with an asterisk. B. taurus PSST residues that were photoaffinity labeled by a 
photoreactive derivative of fenpyroximate are indicated in grey font (Shiraishi et al., 2012). B) 
Bar plot showing A94V and H92R frequency in 20 males of Rasht (susceptible population), 
Lahijan, Ramsar and Sari (resistant populations). 
 
Figure 3 - Toxicity of fenpyroximate to A94V mutant and nos.Cas9 fly lines as assessed by 
a topical assay. No significant differences (as assessed by a Mann-Whitney-U test) in mean 
fenpyroximate mortality were found between the different lines. 
 
Figure 4 - Dose-response relationships of tebufenpyrad, fenpyroximate and pyridaben to 
the inhibition of complex I of nos.Cas9 and A94V fly lines . METI-I inhibition is expressed as 


















Table 1 - Toxicity of fenpyroximate with and without synergists to female adults of P. citri  
a
 the total number of mites used for all concentrations  
b 
the LC50 value is expressed as mg a.i. L
-1
 and their 95% confidence intervals (95% CI); an asterisk indicates 
whether there is a significant difference between synergist+fenpyroximate treatment and treatment with 
fenpyroximate alone (based on 95% CI of SR) 
c
RR, Resistance ratio= LC50 of acaricide/LC50 of susceptible (Rasht) population 
d


















fenpyroximate 240 6.572 (5.850-7.464) 4.309± 0.674 0.492(2)   
PBO 240 2.261 (1.803-3.028)* 2.249± 0.368 0.608 (2)  2.953 (2.244-3.885) 
DEM 240 6.540 (5.840-7.382) 4.436 ±0.706 1.818 (2)  1.034 (0.882-1.213) 
TPP 240 5.263 (4.156-7.406) 2.100 ± 0.398 0.263 (2)  1.285 (0.960-1.720) 
Gorgan 
fenpyroximate 240 47.690 (27.273-84.616) 2.056 ±0.352 4.624 (3) 7.257 (5.699-9.240)  
PBO 240 14.777 (9.625-22.243)* 3.696 ±0.434 7.533 (3) 6.537(4.930-8.668) 3.227 (2.514-4.143) 
DEM 240 39.068 (32.544-52.575) 2.650±0.581 1.052 (2) 5.695 (4.716- 6.879) 1.221 (0.904-1.649) 
TPP 240 24.661 (19.158-35.073)* 1.916± 0.384 0.676 (2) 4.129(2.965-5.750) 1.934 (1.362- 2.745) 
Rahimabad 
fenpyroximate 240 46.193 (38.111-57.284) 2.270±0.351 2.939 (3) 7.029 (5.582-8.851)  
PBO 240 7.318 (6.236-8.991)* 3.079± 0.552 1.208 (2) 3.036 (2.295-4.017) 6.313 (4.852-8.212) 
DEM 240 31.048 (26.628-36.761)* 3.209±0.588 0.113 (2) 4.729 (3.946-5.668) 1.737(1.355-2.228) 
TPP 240 18.117 (14.759-23.871)* 2.456± 0.419 0.306 (3) 3.337 (2.412-4.617) 2.978 (2.204-4.023) 
Talesh 
fenpyroximate 240 130.389 (105.711-166.619) 2.048±0.358 2.254 (3) 19.840 (15.49-25.412)  
PBO 240 25.299 (21.055-31.462)* 2.680± 0.44 1.499 (2) 10.822 (8.041-14.565) 5.154 (3.853-6.894) 
DEM 240 94.989 (77.552-117.239)* 2.487±0.436 0.145 (2) 13.747 (11.258-16.787) 1.373 (1.023-1.842) 
TPP 240 65.086 (56.197-75.777)* 3.452± 0.56 1.284 (2) 12.521(9.228-16.990) 2.003 (1.543-2.601) 
Lahijan 
fenpyroximate 240 131.980 (118.429-147.434) 4.160 ± 0.862 0.365 (3) 19.883 (15.979-24.740)  
PBO 240 31.153 (23.814-43.954)* 1.778± 0.42 0.240 (2) 12.623 (9.162-17.391) 4.237 (3.154-5.691) 
DEM 240 113.636 (97.982-143.770) 3.384± 0.681 0.275 (2) 16.442 (13.959-19.367) 1.161 (0.946-1.426) 
TPP 240 97.295 (82.270-125.775)* 3.183 ± 0.571 0.525 (2) 17.794 (12.743-24.846) 1.356 (1.083-1.699) 
Ramsar 
fenpyroximate 240 > 500   > 76.08  
PBO 240 > 500   > 221.141 / 
DEM 240 > 500   > 76.542 / 
TPP 240 > 500   > 95.002 / 
Sari 
fenpyroximate 240 > 500   > 76.08  
PBO 240 > 500   > 221.141 / 
DEM 240 > 500   > 76.542 / 















Table 2 - Toxicity of pyridaben and tebufenpyrad to four populations of P. citri 
Treatment Population n
a










Rasht 240 0.918 (0.596-1.446) 1.518±0.979 0.861 (3)  
Lahijan 240 2.510 (1.408-4.043) 1.632±0.150 5.813 (3) 2.733 (1.280-5.150) 
Ramsar 240 4.178 (3.195-5.493) 1.751±0.150 3.957 (3) 4.703 (3.210-6.810) 
Sari 240 28.740 (25.450-32.250) 2.178±0.210 1.752 (3) 31.725 (26.780-37.301) 
tebufenpyrad 
Rasht 240 4.104 (3.520-4.760) 0.461±0.069 0.991 (3)  
Lahijan 240 77.844 (68.850-88.690) 3.407±0.306 4.392 (3) 18.967 (15.660-23.201) 
Ramsar 240 83.965 (63.920-109.490) 6.595±0.577 2.607 (3) 23.490 (15.580-34.710) 




the total number of mites used for all concentrations  
b 
the LC50 value is expressed as mg a.i. L
-1
 and their 95% confidence intervals (95% CI) 
c 









































































































*means followed by the same letter in a column are not significantly different at 5% probability level (Tukey). 















Table 4 - Toxicity of fenpyroximate and pyridaben to female adults of P. citri of back-crossed lines S1 and S2 



















Rasht 240 6.572 (5.544-7.983) 4.309 ± 0.953 0.492 (2)  




1.112 ± 0.225 3.462 (4) 
9.169 (5.224-
16.094) 














Rasht 240 0.918 (0.596-1.446) 1.518±0.979 0.861 (3)  
S1 240 0.587 (0.456-0.807) 2.609 ± 0.565 1.905 (3) 0.637 (0.480-0.844) 
R1 240 1.665 (1.337-2.073) 2.826 ± 0.489 0.152 (4) 1.736 (1.352-2.229) 
S2 240 0.756 (0.436-2.50) 1.468 ± 0.443 1.643 (2) 0.823 (0.731-1.728) 
R2 240 1.365 (0.977-1.906) 2.349 ± 0.482 0.029 (2) 1.423 (1.013-1.999) 
Lahijan 240 2.510 (1.408-4.043) 1.632 ± 0.15 5.813 (3) 2.733 (1.280-5.150)  
a
 the total number of mites used for all concentrations  
b 
the LC50 value is expressed as mg a.i. L
-1
 and their 95% confidence intervals (95% CI) 
c 





























Figure S1 - Map of collection sites of P. citri populations from citrus growing regions of 
Northern provinces of Iran 
 
Figure S2 - CRISPR/Cas9 strategy for generation of genome modified flies bearing PSST 
A94V mutation.  
Nucleotide and deduced amino acid sequence of a 873 bp fragment of CG9172 (ND20), 
encompassing the Drosophila melanogaster amino acid sequence. Light gray areas indicate the 
CRISPR/Cas9 targets selected (sgRNA1, sgRNA2, see also Bajda et al., 2017), while dark gray 
areas indicate the corresponding PAM (-NGG) triplets. Vertical arrows denote break points for 
CRISPR/Cas9-induced double stranded breaks. An oval circle marks the non-synonymous 
difference (A94V, Y. lipolytica numbering, corresponding to Drosophila PSST A105V) between 
target (wild-type) and donor (genome modified) sequence. Synonymous mutations incorporated 
for diagnostic purposes, as well as to avoid cleavage of the donor plasmid by the CRISPR/Cas9 
machinery, are shown above the nucleotide sequence. Restriction site Tsp45I, abolished due to 
genome modification, is shown with strikethrough letters and the corresponding sequence is 
underlined. Restriction site SgrBI, introduced because of the genome modification, is shown in a 
dashed box and the corresponding sequence is also underlined. Horizontal arrows indicate the 
positions of primer pair CG9172_ver F/R (Table S4) used for sequencing of the genome 
modified alleles.  
Figure S3 - Screening for genome-modified flies.  
A) PCR screening of individual G1 flies derived from different G0 (injected) individuals using a 
specific primer pair (CG9172_dia_F/R) that generates a 294 bp diagnostic fragment for A94V 
(Y. lipolytica numbering, corresponding to Drosophila A105V) mutation positives [-: nos.Cas9 
DNA (negative control), +: donor plasmid template (positive control)]. B) Screening of G1 flies 
for A94V allele following PCR amplification with a “generic” primer pair (CG9172_ver F/R), 
and digestion of the 559 bp product with SgrBI. The wild-type allele remains uncut, while the 
genome modified A94V allele is cut in two smaller bands of 328 and 231 bp respectively [-: 
nos.Cas9 DNA (negative control), +: donor plasmid template (positive control)]. C) Sequencing 
of the relevant PSST (ND20) region in homozygous genome modified flies. The deduced amino 
acid sequence is shown on top of the nucleotide sequence. Ovals indicate nucleotides differing in 
relation to the wild-type sequence. The genome modified GTT codon (A94V) is shown within a 
dashed square. The SgrBI site introduced is underlined. 
 
Figure S4 - Drosophila crossing scheme for genome modification in the X chromosome 
(modified from Samantsidis et al., 2019). Several nos.Cas9 G0 embryos were injected and 
surviving adults back-crossed to nos.Cas9. The G1 progeny is sampled (n≈30) and screened as 
described in section 2.10.2. Individual G1 flies from positive original G0 crosses were back-
crossed with nos.Cas9 and after generating G2 progeny, they underwent molecular screening 
(single fly PCR) for homologous directed repair (HDR). Positive crosses now contain the mutant 
allele in 50% of the G2 progeny. Individual female G2 flies were then crossed with male flies 













(Bar) and after producing G3 progeny, they were again individually screened to identify positive 
crosses. Individual G3 females with heterozygous Bar phenotype are crossed to the balancer 
strain males and then screened for HDR. G4 females with Bar phenotype (bearing the desired 
mutation opposite to FM7c) are crossed with male siblings selected against Bar (i.e. hemizygous 
for the genome modified chromosome bearing the HDR-derived allele) and their progeny (G5) is 
selected against Bar to generate homozygous lines bearing the desired mutations. 
  
Figure S5 - RT-qPCR validation of a selection of DETs between the Sari and Rasht 
population. Error bars represent 95% CI, while an asterisk indicates significant (p-value < 0.05) 
expression differences between Sari and Rasht. 
 
Figure S6 - Toxicity of tebufenpyrad, pyridaben and fenpyroximate to A94V mutant and 
nos.Cas9 fly lines as assessed by contact assays. Significant differences in mean mortality, as 




File S1 - Sequence of PSST in donor plasmid (FASTA-format) 
 
File S2 - Merged P. citri transcriptome assembly (FASTA-format). 
 
File S3 - Transcriptome assembly of the Rasht, Lahijan, Ramsar and Sari P. citri 
population. 
Supplementary Tables 
Table S1 - Kallisto read mapping statistics against the merged transcriptome P. citri 
assembly (File S2) 
 
Table S2 - Blast2GO analysis of the merged transcriptome assembly (File S2). 
 
Table S3 - Citrus sp. or viral transcripts that were removed before differential transcript 
expression analysis 
 
Table S4 - Primers used in this study 
 
Table S5 - Conditions and components for PCR experiments with P. citri DNA 
 
Table S6 - Differentially expressed transcripts between the fenpyroximate resistant P. citri 
populations Lahijan, Ramsar and Sari and the susceptible populations Rasht. 
 
Table S7 - Overlap between differentially expressed transcripts of the fenpyroximate 














Table S8 - Significantly enriched GO-terms in differentially expressed transcripts between 















 fenpyroximate resistance was investigated in seven Panonychus citri populations from 
Iran 
 fenpyroximate resistance ratios reached up to 75-fold and cross-resistance with other 
METI-I acaricides was observed 
 PBO synergism experiments, in vivo assays and expression analysis suggest a minor role 
for P450s in fenpyroximate resistance 
 a H92R mutation in the PSST subunit, previously associated with METI-I target-site 
resistance, was detected in a highly resistant P. citri population 
 a new PSST mutation, A94V, was detected in a resistant population but no clear claim 
regarding its role in resistance could be made 
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